Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

10.99

-0.13 (-1.17%)

At close: Sep 29, 2026, 4:00 PM EDT

11.14

+0.15 (1.36%)

After-hours: Sep 29, 2026, 7:42 PM EDT

Kailera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,425	-	-
Market Cap Growth	-	-	-
Enterprise Value	263	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.01	0.02	0.00
Net Debt / Equity Ratio	-1.04	-1.01	-1.02
Net Debt / EBITDA Ratio	3.71	4.06	7.15
Net Debt / FCF Ratio	5.19	5.25	0.94
Quick Ratio	11.03	11.83	25.35
Current Ratio	11.11	12.02	25.70
Return on Equity (ROE)	-	-36.90%	-
Return on Assets (ROA)	-	-22.73%	-
Return on Capital Employed (ROCE)	-27.80%	-24.50%	-14.30%

SEC Filings: 10-K · 10-Q